PB Immune Therapeutics is biotech company founded in 2021 and located in Seoul, South Korea focusing on developing immunomodulatory therapeutics including monoclonal antibodies and cell therapies for treatment of autoimmune diseases. It is the culmination of over 16 years of dedicated research and over $36.5M in Korean government research funding in the field of xenotrans ...View more